Agrawal A, Basnet P, Thakur A, Rizal P, Rai R
B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
JNMA J Nepal Med Assoc. 2014 Apr-Jun;52(194):785-90.
Rapid expulsion of fetus in intrauterine fetal death is usually requested without any medical grounds for it. So an efficient, safe method for induction of labor is required. The objective of this study is to determine if pre-treatment with mifepristone followed by induction of labor with misoprostol in late intrauterine fetal death is more efficacious.
We conducted a randomized controlled trial in 100 patients in B.P.Koirala Institute of Health Sciences, Nepal from June 2011 to May 2013. Group A women received single oral dose of 200 mg mifepristone, followed by induction with vaginal misoprostol after 24 hours. Group B women were induced only with vaginal misoprostol. In each group, five doses of misoprostol was used four hourly. If first cycle was unsuccessful, after break of 12 hour, second course of misoprostol was started. The primary outcome was a measure of induction to delivery time and vaginal delivery within 24 hours. Secondary outcome was to measure need of oxytocin and complications.
Maternal age, parity and period of gestation were comparable between groups. Number of misoprostol dose needed in group A was significantly less than group B. Mann Whitney U test showed, women in group A had significantly earlier onset of labor, however total induction to delivery interval was not significant. In group A, 85.7% delivered within 24 hours of first dose of misoprostol while in group B 70% delivered within 24 hours (p=0.07). More women in Group B required oxytocin.
Pretreatment with mifepristone before induction of labor following late intrauterine fetal death is an effective and safe regimen. It appears to shorten the duration of induction to onset of labor.
宫内死胎时通常在没有任何医学依据的情况下要求迅速娩出胎儿。因此,需要一种有效、安全的引产方法。本研究的目的是确定在晚期宫内死胎中,先用米非司酮预处理,然后用米索前列醇引产是否更有效。
2011年6月至2013年5月,我们在尼泊尔BP柯伊拉腊健康科学研究所对100例患者进行了一项随机对照试验。A组妇女口服单剂量200mg米非司酮,24小时后用阴道米索前列醇引产。B组妇女仅用阴道米索前列醇引产。每组每4小时使用5剂米索前列醇。如果第一个周期不成功,在间隔12小时后,开始第二个米索前列醇疗程。主要结局指标是引产至分娩的时间以及24小时内阴道分娩情况。次要结局指标是催产素的使用需求和并发症情况。
两组之间产妇年龄、产次和孕周具有可比性。A组所需米索前列醇剂量明显少于B组。曼-惠特尼U检验显示,A组妇女引产开始时间明显更早,但引产至分娩的总间隔时间无显著差异。A组中,85.7%在第一剂米索前列醇后24小时内分娩,而B组中70%在24小时内分娩(p = 0.07)。B组中更多妇女需要使用催产素。
晚期宫内死胎引产之前用米非司酮预处理是一种有效且安全的方案。它似乎缩短了引产至分娩开始的时间。